Bruce & Co., Inc.
13F Reported Value
ⓘ$369.5M
Holdings
41
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Bruce & Co., Inc. disclosed 41 positions worth $369.5M in its Form 13F-HR for Q2 2026, led by $ABBV (AbbVie Inc.) at 8.2% of the equity portfolio, followed by $ALL and $AER. The portfolio is most concentrated in Healthcare (30.4% of disclosed assets). All figures are sourced directly from Bruce & Co., Inc.’s Form 13F-HR filing with the SEC under CIK 1358331.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 72.6#148
Quality
$30.4M121,000 sh - 78.5#54
Quality
$29.1M122,500 sh - —
Quality
$27.0M185,000 sh - 64.6
Quality
$25.8M294,300 sh - 59.9
Quality
$24.5M190,800 sh - 47.7
Quality
$24.1M417,000 sh - 56.4
Quality
$18.3M144,816 sh - 58.1
Quality
$18.2M48,000 sh - 56.4
Quality
$14.7M182,500 sh - 57.3
Quality
$11.7M153,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 72.6#148 | $30.4M | 121,000 | |
| 78.5#54 | $29.1M | 122,500 | |
| — | $27.0M | 185,000 | |
| 64.6 | $25.8M | 294,300 | |
| 59.9 | $24.5M | 190,800 | |
| 47.7 | $24.1M | 417,000 | |
| 56.4 | $18.3M | 144,816 | |
| 58.1 | $18.2M | 48,000 | |
| 56.4 | $14.7M | 182,500 | |
| 57.3 | $11.7M | 153,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Bruce & Co., Inc.'s 41 positions.
Showing top 10 of 41 holdings.
Sector Allocation
Healthcare
$112.5M
Utilities
$79.2M
Financials
$31.5M
Technology
$29.5M
Consumer Discretionary
$28.8M
Industrials
$27.0M
Materials
$25.2M
Consumer Staples
$21.8M
Full Holdings — Bruce & Co., Inc. (Q2 2026)
All 41 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | AbbVie Inc. | $30.4M | 8.2% | -1% | 72.6 | |
| 2 | ALLSTATE CORP | $29.1M | 7.9% | -2% | 78.5 | |
| 3 | AerCap Holdings N.V. | $27.0M | 7.3% | +1% | — | |
| 4 | NEXTERA ENERGY INC | $25.8M | 7.0% | -2% | 64.6 | |
| 5 | Merck & Co., Inc. | $24.5M | 6.6% | -1% | 59.9 | |
| 6 | U-Haul Holding Co /NV/ | $24.1M | 6.5% | -8% | 47.7 | |
| 7 | Duke Energy CORP | $18.3M | 5.0% | -1% | 56.4 | |
| 8 | VICOR CORP | $18.2M | 4.9% | -26% | 58.1 | |
| 9 | XCEL ENERGY INC | $14.7M | 4.0% | -1% | 56.4 | |
| 10 | CMS ENERGY CORP | $11.7M | 3.2% | -2% | 57.3 | |
| 11 | AT&T INC. | $10.7M | 2.9% | -1% | 65.7 | |
| 12 | Apple Inc. | $10.7M | 2.9% | -5% | 76.4 | |
| 13 | Beta Bionics, Inc. | $10.4M | 2.8% | +21% | 29.8 | |
| 14 | INSTEEL INDUSTRIES INC | $10.4M | 2.8% | +0% | 51 | |
| 15 | ABBOTT LABORATORIES | $10.2M | 2.8% | -1% | 65.5 | |
| 16 | NEWMONT Corp /DE/ | $9.3M | 2.5% | +0% | 86.8 | |
| 17 | AVISTA CORP | $8.2M | 2.2% | -1% | 54.2 | |
| 18 | Archer-Daniels-Midland Co | $7.6M | 2.1% | +0% | 50.7 | |
| 19 | Bunge Global SA | $7.5M | 2.0% | +0% | 54.5 | |
| 20 | SUPERNUS PHARMACEUTICALS, INC. | $7.0M | 1.9% | +50% | 41.9 | |
| 21 | PFIZER INC | $6.5M | 1.8% | -1% | 62 | |
| 22 | DARLING INGREDIENTS INC. | $5.7M | 1.6% | -1% | 63.5 | |
| 23 | Kodiak Sciences Inc. | $5.6M | 1.5% | +0% | — | |
| 24 | Chemours Co | $5.1M | 1.4% | +0% | 43.4 | |
| 25 | U-Haul Holding Co /NV/ | $4.8M | 1.3% | -2% | 47.7 | |
| 26 | LyondellBasell Industries N.V. | $3.2M | 0.8% | +0% | — | |
| 27 | Personalis, Inc. | $3.1M | 0.8% | +0% | 11.3 | |
| 28 | FATE THERAPEUTICS INC | $2.7M | 0.7% | +25% | 9.2 | |
| 29 | ELI LILLY & Co | $2.4M | 0.7% | +0% | 87.5 | |
| 30 | RLI CORP | $2.4M | 0.6% | -2% | 74.5 | |
| 31 | APOGEE ENTERPRISES, INC. | $2.3M | 0.6% | +0% | 51.5 | |
| 32 | EDAP TMS SA | $2.3M | 0.6% | +0% | 17.8 | |
| 33 | SIRIUS XM HOLDINGS INC. | $1.6M | 0.5% | +0% | 61.5 | |
| 34 | Venture Global, Inc. | $1.1M | 0.3% | +0% | 69.5 | |
| 35 | ASHLAND INC. | $988,350 | 0.3% | +0% | 50 | |
| 36 | Viatris Inc | $916,212 | 0.3% | -1% | 45.4 | |
| 37 | MANNKIND CORP | $831,011 | 0.2% | +0% | 37.2 | |
| 38 | — | Bausch Health - Common | $611,320 | 0.2% | +0% | — |
| 39 | 908 Devices Inc. | $594,088 | 0.2% | +0% | 27 | |
| 40 | WEC ENERGY GROUP, INC. | $460,658 | 0.1% | +0% | 60.1 | |
| 41 | Caribou Biosciences, Inc. | $440,000 | 0.1% | +0% | 11.7 |
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Bruce & Co., Inc. including:
Track Bruce & Co., Inc.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Bruce & Co., Inc. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Bruce & Co., Inc.
13F Pro is an AI hedge fund tracker and stock research platform. For Bruce & Co., Inc. (SEC CIK: 1358331), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Bruce & Co., Inc.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.